We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

34 hedge funds and large institutions have $36.2M invested in OncoSec Medical Incorporated in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 4

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

32% more capital invested

Capital invested by funds: $27.4M → $36.2M (+$8.76M)

10% more funds holding

Funds holding: 31 → 34 (+3)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
17
Reduced
4
Closed
6
Calls
$59K
Puts
–
Net Calls
+$59K
Net Calls Change
+$59K

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$9.44M
2
Holocene Advisors
Holocene Advisors
New York
+$4M
3
JGC
J. Goldman & Co
New York
+$2.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.48M
5
CC
Caxton Corporation
New Jersey
+$721K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$801K
2
SFP
Sandbox Financial Partners
Maryland
-$484K
3
SSA
Schonfeld Strategic Advisors
New York
-$401K
4
BFM
Boothbay Fund Management
New York
-$132K
5
Goldman Sachs
Goldman Sachs
New York
-$120K
Name Holding Trade Value Shares
Change 		Change in
Stake
APM
1
Avidity Partners Management
Texas
$16.6M +$9.44M +69,000 +78%
JGC
2
J. Goldman & Co
New York
$4.71M +$2.9M +21,177 +89%
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.15M +$2.48M +18,139 +85%
Holocene Advisors
4
Holocene Advisors
New York
$3.06M +$4M +29,203 New
Renaissance Technologies
5
Renaissance Technologies
New York
$1.63M +$136K +991 +7%
Millennium Management
6
Millennium Management
New York
$817K +$691K +5,052 +185%
Two Sigma Investments
7
Two Sigma Investments
New York
$687K +$254K +1,857 +40%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$674K +$371K +2,712 +73%
DADC
9
D.A. Davidson & Co
Montana
$558K -$6.29K -46 -0.9%
CC
10
Caxton Corporation
New Jersey
$553K +$721K +5,267 New
Two Sigma Advisers
11
Two Sigma Advisers
New York
$535K +$490K +3,582 +236%
SCM
12
Stonepine Capital Management
Oregon
$452K +$590K +4,308 New
BlackRock
13
BlackRock
New York
$298K +$13.1K +96 +3%
Squarepoint
14
Squarepoint
New York
$248K +$324K +2,365 New
Northern Trust
15
Northern Trust
Illinois
$207K +$99.9K +730 +59%
SSA
16
Schonfeld Strategic Advisors
New York
$199K -$401K -2,928 -61%
SM
17
Salzhauer Michael
$178K +$62.3K +455 +37%
ECM
18
ExodusPoint Capital Management
New York
$155K +$85.3K +623 +73%
TAM
19
Tocqueville Asset Management
New York
$98K +$128K +932 New
Citadel Advisors
20
Citadel Advisors
Florida
$86K +$30.7K +224 +38%
HF
21
HRT Financial
New York
$74K +$97.7K +714 New
SPC
22
Sigma Planning Corp
Michigan
$69K -$114K -832 -56%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$54K – – –
JF
24
Jump Financial
Illinois
$51K +$66K +482 New
PAG
25
Private Advisor Group
New Jersey
$50K – – –
1
2

ONCS Hedge Fund Activity: Q1 2021 in Review

34 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2021, worth a combined $36.2M — up 32% from $27.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ONCS positions and 6 closed out — a net gain of 4 holders — while 17 added to existing stakes and 4 trimmed.

The largest buyer was Avidity Partners Management, adding an estimated $9.44M. The largest seller was 683 Capital Management, exiting entirely with an estimated $801K sold.

  • 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2021, up from 31 in Q4 2020.
  • Funds reported $36.2M of OncoSec Medical Incorporated stock for Q1 2021, up 32% quarter-over-quarter.
  • 10 funds opened new OncoSec Medical Incorporated positions in Q1 2021 and 6 closed out, a net change of +4 holders.
  • The largest OncoSec Medical Incorporated buyer in Q1 2021 was Avidity Partners Management, an estimated $9.44M added.
  • The largest OncoSec Medical Incorporated seller in Q1 2021 was 683 Capital Management, an estimated $801K sold.

Based on aggregated 13F filings for Q1 2021.